Malone wrote: changes in the receptor binding domain (RBD) of Spike will not only influence how well it can evade vaccine-induced antibodies, but also how it interacts with ACE 2: I agree, but....
Malone wrote: changes in the receptor binding domain (RBD) of Spike will not only influence how well it can evade vaccine-induced antibodies, but also how it interacts with ACE 2: I agree, but....
we must also consider that with so many mutations on the spike in omicron (RBD), that it has selected to use other cell surface receptors to gain access to the host cell; is this the reason?
Thanks for the quoted studies. These are not new though, some over a year old. So, not related, at least directly, to the latest viral mutations. I suppose the Omicron is a godsend to us, to even the playing field between the vaxxed and unvaxxed, as now the vaxxed are preferably infected. Without health consequences for either - a perfect natural vaccination campaign bypassing the vaxxing. A golden opportunity to change the terms of engagements for/by the ppl, as it were. act now, as the gov'ts clamp down according with the WEF programme.
Thanks for the quoted studies. These are not new though, some over a year old. So, not related, at least directly, to the latest viral mutations. I suppose the Omicron is a godsend to us, to even the playing field between the vaxxed and unvaxxed, as now the vaxxed are preferably infected. Without health consequences for either - a perfect natural vaccination campaign bypassing the vaxxing. A golden opportunity to change the terms of engagements for/by the ppl, as it were. act now, as the gov'ts clamp down according with the WEF programme.
Does Dr Malone, and others, have current clinical experience?